172 related articles for article (PubMed ID: 34442383)
21. The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.
Althobiti M; Muftah AA; Aleskandarany MA; Joseph C; Toss MS; Green A; Rakha E
Breast Cancer Res Treat; 2020 Aug; 182(3):581-589. PubMed ID: 32524353
[TBL] [Abstract][Full Text] [Related]
22. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
[TBL] [Abstract][Full Text] [Related]
23. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
[TBL] [Abstract][Full Text] [Related]
24. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
Pietersen AM; Horlings HM; Hauptmann M; Langerød A; Ajouaou A; Cornelissen-Steijger P; Wessels LF; Jonkers J; van de Vijver MJ; van Lohuizen M
Breast Cancer Res; 2008; 10(6):R109. PubMed ID: 19099573
[TBL] [Abstract][Full Text] [Related]
25. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications.
Wang H; Liu H; Li X; Zhao J; Zhang H; Mao J; Zou Y; Zhang H; Zhang S; Hou W; Hou L; McNutt MA; Zhang B
BMC Cancer; 2014 Feb; 14():122. PubMed ID: 24559156
[TBL] [Abstract][Full Text] [Related]
27. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
28. PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
Li J; Vangundy Z; Poi M
Anticancer Res; 2020 Jan; 40(1):133-141. PubMed ID: 31892561
[TBL] [Abstract][Full Text] [Related]
29. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S
Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391
[TBL] [Abstract][Full Text] [Related]
30. BMI1 sustains human glioblastoma multiforme stem cell renewal.
Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
[TBL] [Abstract][Full Text] [Related]
31.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
32. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
[TBL] [Abstract][Full Text] [Related]
33. Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis.
Tsai YT; Wu CC; Ko CY; Hsu TI; Chang WC; Lo WL; Chuang JY
Biochem Biophys Res Commun; 2021 Apr; 550():113-119. PubMed ID: 33691197
[TBL] [Abstract][Full Text] [Related]
34. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
[TBL] [Abstract][Full Text] [Related]
35. The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy.
Yoshikawa R; Tsujimura T; Tao L; Kamikonya N; Fujiwara Y
BMC Cancer; 2012 Oct; 12():461. PubMed ID: 23046527
[TBL] [Abstract][Full Text] [Related]
36. Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
Oliva CR; Markert T; Gillespie GY; Griguer CE
Oncotarget; 2015 Feb; 6(6):4330-44. PubMed ID: 25726526
[TBL] [Abstract][Full Text] [Related]
37. Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer.
Sugihara H; Ishimoto T; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Komohara Y; Takeya M; Baba H
PLoS One; 2013; 8(11):e81839. PubMed ID: 24312366
[TBL] [Abstract][Full Text] [Related]
38. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery.
Facchino S; Abdouh M; Chatoo W; Bernier G
J Neurosci; 2010 Jul; 30(30):10096-111. PubMed ID: 20668194
[TBL] [Abstract][Full Text] [Related]
39. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
[TBL] [Abstract][Full Text] [Related]
40. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]